Genmab A/S GMAB 深 沪
已收盘 08-01 16:00:00 美东时间
21.78
+0.110
+0.51%
华盛通- 最 高21.785
- 今 开21.42
- 成交量 120.45万股
- 最 低 21.26
- 昨 收 21.67
- 总市值 133.95亿
- 52周最高 27.94
- 市盈率 静 12.38
- 换手率 0.20%
- 52周最低 17.235
- 委 比 -89.65%
- 总股本 6.15亿
- 历史最高 49.07
- 量 比 1.63
- 振 幅 2.42%
- 历史最低 16.24
- 每 手 1
- 风险率 2.31%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多【太平洋医药】板块持续放量，创新产业链和疫苗关注度提升（附4-1BB靶点药物研究）
（来源：市场投研资讯） 本周观点 本周，我们梳理了4-1BB靶点作用机制，重点关注PD-L1/4-1BB的临床进展。 4-1BB是极具潜力的肿瘤治疗靶点，关注...
07-29 10:54
Breaking Down BioNTech: 12 Analysts Share Their Views
BioNTech (NASDAQ:BNTX) underwent analysis by 12 analysts in the last quarter, r...
07-16 20:02
J&J boosts full-year outlook on forex tailwinds and operational performance
Johnson & Johnson (NYSE:JNJ) traded higher in the premarket on Wednesday as the healthcare giant started pharma earnings season, lifting its full-year outlook after reporting better-than-expected fina...
07-16 19:04
Genmab reports Q2 Darzalex net sales of $3.54 billion
Genmab A/S (GMAB) said Wednesday that net sales of Darzalex in the second quarter of 2025 totaled $3,539 million. Net trade sales were $2,017 million in the U.S. and $1,521 million in the rest of the ...
07-16 18:48
Genmab Q2 Worldwide Net Trade Sales Of DARZALEX Totals $3.539B
Net sales of DARZALEX® in the second quarter of 2025 totaled USD 3,539 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc.)COPENHAGEN,
07-16 18:32
AbbVie and Genmab’s Epcoritamab Trial: A Promising Update for B-NHL Treatment
Abbvie (($ABBV)), Genmab (Otc) (($GMAB)), Abbvie (($CC:ABBV.CUR)) announced an ...
07-11 00:33
美股大行评级 | 潜在涨幅687%！ 花旗上调新氧科技目标价升至5.5美元，评级"买入"
今日重点评级关注：B. Riley证券：维持内克塔治疗"买入"评级，目标价从60美元升至85美元；Oppenheimer：维持Praxis Precision Medicine"跑赢大市"评级，目标价从97美元升至115美元
07-09 09:26
Truist Securities Maintains Buy on Genmab, Raises Price Target to $46
Truist Securities analyst Asthika Goonewardene maintains Genmab (NASDAQ:GMAB) with a Buy and raises the price target from $45 to $46.
07-08 23:59
2025，医疗健康投什么
原标题：2025，医疗健康投什么 科技创新浪潮奔涌，产业变革方兴未艾。眼下技术迭代持续加速、产业边界深度重构，高成长企业正以澎湃动能重塑全球产业格局。由清科创...
06-26 14:09
Expert Outlook: BioNTech Through The Eyes Of 11 Analysts
Throughout the last three months, 11 analysts have evaluated BioNTech (NASDAQ:B...
06-25 20:00
